New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
09:10 EDTBIIB, MLNX, LTD, KSS, SPWR, TGT, JWN, ROST, FDO, GPSOn The Fly: Pre-market Movers
HIGHER AFTER SSS REPORTS: Ross Stores (ROST), up 5.1%... Nordstrom (JWN), up 3.5%... Target (TGT), up 2.9%... ALSO HIGHER: Gap (GPS), up 4% after report of December SSS up 5%, along with $1B stock-buyback plan and deal to buy Intermix for $130M... SunPower (SPWR), up 15.5% after upgrade to Buy at Lazard Capital... LOWER AFTER EARNINGS: Family Dollar (FDO), down 9.6%... LOWER AFTER SSS REPORTS: Limited (LTD), down 5%... Kohl's (KSS), down 2.4%... ALSO LOWER: Melanox (MLNX), down 18.6% after Q4 revenue warning prompts numerous price target cuts around Street... Biogen Idec (BIIB), down 5.4% after ALS drug misses endpoint, development discontinued.
News For GPS;FDO;ROST;JWN;TGT;SPWR;KSS;LTD;MLNX;BIIB From The Last 14 Days
Check below for free stories on GPS;FDO;ROST;JWN;TGT;SPWR;KSS;LTD;MLNX;BIIB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 24, 2014
16:27 EDTMLNXMellanox sees Q3 revenue $114M-$118M, consensus $113.78M
Sees Q3 Non-GAAP gross margins of 68%-69%.
16:27 EDTMLNXMellanox reports Q2 EPS 15c, consensus 10c
Reports Q2 revenue $102.6M, consensus $102.6M.
09:07 EDTBIIBBiogen price target raised to $474 from $432 at BMO Capital
Subscribe for More Information
06:24 EDTBIIBBiogen price target raised to $387 from $343 at Citigroup
Citigroup raised its price target for Biogen shares to $387 citing the company's earnings and revenue growth following its better than expected Q2 results. Citi keeps a Buy rating on the stock.
July 23, 2014
11:43 EDTBIIBBiogen announces PLEGRIDY EC approval
Subscribe for More Information
10:25 EDTBIIBBiogen price target raised to $420 from $370 at Piper Jaffray
Subscribe for More Information
09:50 EDTBIIBBiogen says strategic bias still tuck-in acquisitions
Subscribe for More Information
09:37 EDTBIIBBiogen says 'clearly' has considered tax inversion
Subscribe for More Information
09:25 EDTBIIBBiogen sees Japan as an attractive growth opportunity for company
Says remains committed to SG&A leverage in 2014. Says guidance assumes Tecfidera EU uptake similar to U.S.
09:17 EDTBIIBOn The Fly: Pre-market Movers
Subscribe for More Information
09:05 EDTBIIBBiogen says received letter from EU saying PLEGRIDY has been approved
Subscribe for More Information
08:56 EDTBIIBBiogen still sees FY CapEx approximately $300M
Believes TECFIDERA is on track to become the leading MS product in the U.S. Says outside the U.S., demand for TECFIDERA has been broad; launch trajectories similar to experience in U.S. Continues to be in discussions with AIFA to resolve its dispute on Tysabri for February 2009-January 2013. Says FY guidance "meaningfully increased" due primarily to the  growth  of  TECFIDERA in the U.S. and the EU., the strength of our other MS therapies and clarity on the AIFA pricing matter. Comments from slides that will be presented on the Q2 earnings conference call.
06:50 EDTBIIBBiogen raises FY14 EPS to $12.90-$13.10 from $11.35-$11.45, consensus $11.53
Subscribe for More Information
06:48 EDTBIIBBiogen reports Q2 Tecfidera revenue $700M; Reports Q2 Avonex revenue $774M
Subscribe for More Information
06:47 EDTBIIBBiogen reports Q2 adjusted EPS $3.49, consensus $2.83
Reports Q2 revenue $2.42B, consensus $2.16B; Non-GAAP diluted EPS was benefited by approximately 15c, following the approval from an agreement with the Italian National Medicines Agency relating to Tysabri sales in Italy.
July 22, 2014
16:35 EDTMLNXMellanox initiated with an Outperform at Imperial Capital
Subscribe for More Information
14:30 EDTBIIBBiogen technical remarks ahead of earnings
Subscribe for More Information
July 21, 2014
14:02 EDTGPSGap expands brand to Slovenia and Austria
Gap announced that it will introduce the Gap brand to Slovenia and Austria through agreements with new and existing franchise partners. Magistrat International has been selected for the launch of Slovenia and Gottex, which currently manages the Gap franchise business in Israel and Hungary, will launch Austria. Gap has signed a new agreement with Magistrat International to open three stores for the first time later this year in the capital city of Ljubljana. City Park. All locations are scheduled to open by September this year. Gap will also open its first store in Vienna, Austria this October through an existing relationship with Gottex Brands, which is a part of the Trimera Group.
08:34 EDTROSTRoss Stores opens 30 new locations in June and July
Ross Stores announced the June and July openings of 23 Ross Dress for Less and seven dd's DISCOUNTS stores across 17 different states. These new locations are part of the off-price retailer's plans to add a total of approximately 75 Ross and 20 dd's DISCOUNTS stores during 2014.
07:37 EDTBIIBBiogen July weekly volatility elevated into Q2 and outlook
Biogen July weekly call option implied volatility is at 55, August is at 34, October is at 36; compared to its 26-week average of 33 according to Track Data, suggesting large near term price movement into the expected release of Q2 on July 23.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use